IRAK
Phase 1b Study of R289 in Patients with Lower-risk Myelodysplastic Syndromes (LR MDS)
Arms / Cohorts
Experimental:Exploratory Phase 1B
Not Evaluated
Accepting patients
Experimental:Dose Expansion
Not Evaluated
Accepting patients
Experimental:Dose Escalation
Not Evaluated
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.